Michael Linnebacher was born on July 5, 1969, in Ottweiler, Germany. He graduated from the Department of Biology, Universität des Saarlandes, Saarbrücken, Germany in 1996; obtained a Diploma in biology in 1996, Institut of internal medicine, Universität des Saarlandes, Homburg, Germany, with a thesis entitled "Proteinchemische analyse eines zellzyklusabhängigen, nucleären autoantigens und analyse der assoziation mit nucleinsäuren"; and received his Ph.D. degree in biology in July 2001, Institut of Immunology, Ruprecht-Karls-University Heidelberg, Germany, with a thesis entitled "Immunogene neopeptide von leserastermutierten, kodierenden mikrosatelliten – eine neue klasse von tumorantigenen." Linnebacher worked as a Research Assistant at the University Hospital Heidelberg, Department of Molecular Pathology from 2001 to 2005. He is the Founder of the working group Molecular Oncology and Immunotherapy as a section of the Department of General Surgery of the University of Rostock, since 2005. He completed his habilitation in experimental oncology in 2009. Linnebacher is currently a Member of the steering committees Colonet and Tumor Tissue Banks of the German cancer aid, since 2009. His research interests include individual tumor models, colorectal carcinoma, and tumor immunology.
Biography Updated on 9 September 2014